| This week's sponsor is Premier Research. | | | Opportunity Knocks: Seizing the Promise of Orphan Drugs
Orphan drug developers enjoy more favorable regulatory conditions today than ever. Read our white paper for tips on maximizing this opportunity. Premier Research. It's what we do. Best. |
Today's Rundown Ferring Pharma snags a microbiome platform with Rebiotix buy Boehringer, OSE tie up in I-O deal that could total more than $1.4B Nordic Nanovector further delays pivotal lymphoma readout, parts company with CEO [Sponsored] Personalized Medicine Requires Personalized Measurement Conatus shares fall on phase 2 data for Novartis-partnered NASH drug emricasan Amgen backs Harvard professors’ ALS startup QurAlis Eye implant made from stem cells could halt macular degeneration Apple launches Health Records with 39 health systems. How soon will it reach clinical studies? Featured Story | | | Thursday, April 5, 2018 While Ferring Pharma is "intrigued" by Rebiotix's lead asset, a fecal microbiota transplant to prevent recurrent C. difficile infections, it sees the deal as an R&D acquisition that will keep delivering beyond the "front-runner project." |
|
|
| This week's sponsor is STEMCELL Technologies. | | | |
Top Stories Wednesday, April 4, 2018 Boehringer Ingelheim picked up the global rights to OSE's SIRP-alpha antagonist, which is currently in preclinical trials in various solid tumors. Thursday, April 5, 2018 Nordic Nanovector has further delayed a readout from its pivotal lymphoma trial, pushing a planned regulatory filing out to three years after the initial target. The latest setback marks the end of the line for Luigi Costa, who is stepping down as CEO. Monday, April 2, 2018 How we measure outcomes will evolve from applying one solution to finding an empirical basis for a highly customized application of all of them. Personalized medicine needs a more personalized approach to measurement. Read more. Thursday, April 5, 2018 Conatus Pharma’s lead drug emricasan missed the mark in its first midstage clinical test, driving down its stock despite the company’s efforts to put a positive spin on the data. Thursday, April 5, 2018 QurAlis has raised seed funding from a syndicate featuring Amgen Ventures. The startup will use the cash to advance treatments for three subtypes of amyotrophic lateral sclerosis (ALS). Thursday, April 5, 2018 A team of scientists led by the University of Southern California’s Roski Eye Institute built a retinal implant from embryonic stem cells, and they have early but encouraging evidence from a small clinical trial that it may improve visual functioning in people with advanced dry age-related macular degeneration. Thursday, April 5, 2018 Apple has officially launched its Apple Health Records function, which allows users to access EHRs from multiple healthcare providers in one place—and it could change the clinical trial landscape in many ways. | This week's sponsor is Sensors Expo. | | | |
Enrollment Showcase | | | Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. |
|
|
Resources Sponsored by: USDM Life Sciences What are the biggest trends in life sciences this year? Sponsored by: Halo Pharma Why does confidence matter when outsourcing Fixed-Dose Combination products? Download Halo Pharma’s white paper on the importance of product design, technology, and analyticals tools for FDC. Sponsored by: WCG Small biopharma companies are conducting almost 50% of the clinical trials in the US today, yet they face unique challenges that large pharma do not. In this paper, we explore some of those challenges, and solutions that can reduce the pressure on small biopharma teams and timelines. Sponsored by: Veeva Systems Explore a new model for events management, and learn how to deliver more value. Presented by: Patheon, part of Thermo Fisher Scientific Patheon's Stephen Lam reviews the formidable challenges and decisions facing biopharma manufacturing executives. Watch as he shares unique insights and perspectives and demonstrates how there is really no one-size-fits-all solution in biomanufacturing, regardless of company size. Presented by: Charles River How do you get your oncology therapy to the clinic? The path isn’t always clear. In vitro, ex vivo, xenograft, syngeneic, PDX, humanized models, immunology considerations, safety regulations – which do you need to plan for and when? Sponsored by: DocuSign Life science companies are experiencing a significant transformation in how they bring new products to market. Sponsored by: Reprints Desk The competitive landscape in medical device R&D is tough. And simply investing in R&D is no guarantee for profitability. So how do you accelerate time-to-market? Sponsored by: WCG Selecting the right sites to conduct your clinical trials will determine the success or failure of meeting your enrollment goals. Presented by: Covance Global clinical trials are the trend and gaining in popularity, but running a global trial is not a straightforward process. This white paper explores some of the challenges associated with global clinical trials and considerations for ensuring that the collected data comply with the trial's overall objectives. Presented by: Charles River Join us as we discuss how Charles River Celsis® helped Labor L+S AG validate a 7-day membrane filtration sterility test using existing protocols. Presented by: Catalent Learn how Catalent Biologics is paving the way for flexible biologics development and manufacturing through advanced technologies and fully integrated multi-product facility. Presented by: Catalent Download the eBook to get articles from various Elsevier journals highlighting developments in ADC technology. Presented by: Catalent Learn how cell development and process scale-up can be optimized for antibodies requiring additional processing. Sponsored by: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. Drug Approval, Manufacturing Quality & Regulation 2018 | Online Sensors Expo & Conference Conference & Expo: June 26-28, 2018 | Pre-Conference Symposia: June 25, 2018 | San Jose, CA IRT Europe – Interactive Response Technologies in Clinical Trials April 10th-11th, 2018 | Brussels, Belgium Field Service USA 2018 April 17-April 20, 2018 | JW Marriott Palm Desert Resort & Spa, CA
Drug Development Immersion April 25-26, 2018 | New York City Biotech for the Non-Scientist May 2-3, 2018 | San Diego, CA MIXiii-Biomed 2018 May 15-17, 2018 | Tel-Aviv, Israel Drug Development Immersion May 17-18, 2018 | Boston, MA BIO International Convention June 4-7, 2018 | Boston, MA
BioBasics: Biotech for the Non-Scientist June 13 - 14, 2018 | West Windsor, NJ BioBasics: Biotech for the Non-Scientist June 13 - 14, 2018 | Toronto, Canada Drug Development Boot Camp® 2018 November 14-15, 2018 | Boston, MA | Register and start preparing Today! | 